[Home ] [Archive]    
:: Main About journal Editorial Board Current Issue Archive Submit an article Site Map Contact ::
Main Menu
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Contact us::
Site Facilities::
Editorial Board::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: Volume 12, Issue 4 (12-2023) ::
Int J Med Invest 2023, 12(4): 51-57 Back to browse issues page
Hyperthyroidism, Thyroid cancers, and Osteoprosis
Solmaz Askari * , Marzieh Porgholi
Assistant Professor Of Internal Medicine, Department Of Internal Medicine, Faculty Of Medicine, Golestan University Of Medical Sciences, Gorgan, Iran.
Abstract:   (386 Views)
This narrative review explores the intricate relationship between thyroid disorders, both hyperthyroidism and hypothyroidism, and their impact on bone health and fracture risk. Hyperthyroidism, whether overt or subclinical, has been associated with an increased risk of fractures, emphasizing the significance of addressing thyroid dysfunction to prevent fractures. Surgical treatment for hyperthyroidism was found to reduce fracture risk in a nationwide follow- up study, while overt hyperthyroidism was linked to heightened bone turnover, diminished bone density, osteoporosis, and an elevated fracture risk. Additionally, hyperthyroidism's potential to accelerate linear growth and strain on bones further contributes to fracture susceptibility. In
older men, lower levels of thyroid-stimulating hormone (TSH) were associated with a higher risk of hip fractures, indicating a specific connection between thyroid function and hip fracture risk. Graves' disease, often leading to prolonged untreated hyperthyroidism, can result in bone density loss and an increased risk of osteoporosis. The impact of thyroid hormones and thyroid autoantibodies on bone mineral density in premenopausal women with Graves' disease was also explored, revealing a clinically relevant influence of thyroid function on bone modulation. Furthermore, the review discusses the potential protective role of TSH receptor antibodies (TRAb) on bones in patients with Graves' thyrotoxicosis and Graves' orbitopathy. The review concludes by highlighting the importance of monitoring bone health in thyroid disease patients and the need for further research to fully understand these complex interactions.
Keywords: Hyperthyroidism, Thyroid cancers, Osteoprosis
Full-Text [PDF 485 kb]   (201 Downloads)    
Type of Study: Review | Subject: General
Add your comments about this article
Your username or Email:


XML     Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Askari S, Porgholi M. Hyperthyroidism, Thyroid cancers, and Osteoprosis. Int J Med Invest 2023; 12 (4) :51-57
URL: http://intjmi.com/article-1-1081-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 12, Issue 4 (12-2023) Back to browse issues page
International Journal of Medical Investigation
Persian site map - English site map - Created in 0.05 seconds with 37 queries by YEKTAWEB 4645